Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Main subject
Language
Document Type
Year range
1.
Clin Immunol ; 239: 109022, 2022 06.
Article in English | MEDLINE | ID: covidwho-1803761

ABSTRACT

In March 2020, when coronavirus disease 2019 (COVID-19) was just beginning to spread around the world, we presented the potential benefits and controversies of anti-inflammatory therapy in COVID-19 patients based on the limited experience and proposed some types of anti-inflammatory drugs with potential therapeutic value, while without evidence-based data. In the past one more year, many clinical trials or real-world studies have been performed, either confirm or deny the efficacy of certain anti-inflammatory drugs in the treatment of COVID-19. In this review we summarize the progress of anti-inflammatory and immune therapy in COVID-19, including glucocorticoids, IL-6 antagonist, IL-1 inhibitor, kinase inhibitors, non-steroidal anti-inflammatory drugs and chloroquine/hydroxychloroquine.


Subject(s)
COVID-19 , Anti-Inflammatory Agents/therapeutic use , COVID-19/drug therapy , Chloroquine/therapeutic use , Humans , Hydroxychloroquine/therapeutic use , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL